high
mutat
rate
virus
potenti
elud
host
defens
system
well
antivir
drug
vaccin
thu
develop
new
altern
antivir
therapi
becom
past
decad
scientist
wide
use
cellular
rna
interfer
rnai
pathway
approach
target
number
viral
gene
restrain
pathway
long
rna
dsrna
precursor
split
short
interf
rna
sirna
follow
silenc
complex
includ
one
sirna
strand
slice
complementari
target
mrna
use
short
interf
rna
technolog
exploit
target
gene
well
function
also
strategi
target
divers
type
virus
even
tini
viral
genom
provid
sever
target
region
exampl
sirna
direct
differ
gene
deadli
virus
like
human
immunodefici
viru
hiv
influenza
viru
infv
hepat
b
viru
hbv
sar
coronaviru
human
papillomaviru
hpv
west
nile
viru
wnv
infect
cell
display
encourag
result
inhibit
viral
replic
research
also
use
multipl
sirna
simultan
augment
viral
inhibit
coordin
short
interf
rna
variou
human
virus
like
respiratori
syncyti
viru
rsv
hepat
c
viru
hcv
hbv
hiv
also
appear
clinic
trial
elucid
import
inhibit
viral
thu
sirna
emerg
practic
modular
adapt
therapeut
treat
viral
infect
review
discuss
use
sirna
differ
viral
famili
therapeut
applic
design
deliveri
consider
limit
sirna
antivir
remedi
measur
also
discuss
virus
tini
oblig
intracellular
parasit
either
rna
dna
genom
enclos
protein
coat
virus
depend
host
cell
prolifer
classifi
account
shape
genom
structur
mode
replic
mani
class
pathogen
caus
larg
number
diseas
differ
differ
speci
virus
vari
type
infect
process
howev
mani
gener
briefli
summar
figur
short
interf
rna
direct
specif
viralhost
gene
block
viru
life
cycl
step
rnai
cellular
mechan
wherein
small
molecul
rna
hinder
express
particular
gene
via
counteract
correspond
mrna
molecul
possess
nucleotid
sequenc
complimentari
small
histor
rnai
identifi
differ
term
quell
cosuppress
posttranscript
gene
silenc
mello
fire
illustr
strong
gene
silenc
caus
inject
dsrna
caenorhabd
elegan
find
field
rnai
pictori
summar
figur
rnai
pathway
process
dsrna
rna
molecul
act
modul
silenc
machineri
distinct
suppress
expressionfunct
intend
genegenom
region
figur
particular
silenc
pathway
involv
chop
dsrna
sirna
typic
base
pair
long
dsrna
dinucleotid
overhang
termini
one
sirna
strand
guid
strand
incorpor
silenc
complex
degrad
target
sirna
result
origin
longer
dsrna
differ
microrna
latter
gener
partial
base
pair
target
mrna
restrain
express
sever
differ
gene
relat
sequenc
short
interf
rna
also
differ
short
hairpin
rna
latter
hairpin
turn
express
cell
usual
achiev
mean
bacterialvir
short
interf
rna
characterist
complet
caus
mrna
cleavag
precis
target
microrna
gener
intron
gene
gene
silenc
take
place
mrna
cleavag
thwart
mrna
translat
role
microrna
regul
gene
express
plant
kingdom
rnai
broadcast
transport
sirna
amid
cell
via
rnai
describ
breakthrough
year
rnai
also
believ
compon
primit
immun
system
base
nucleic
acid
rnai
shield
human
cell
pathogen
virus
silenc
viral
moreov
small
rna
caus
genom
imprint
facilit
delin
transcript
prototyp
adapt
conform
certain
genom
taxonom
group
consist
nonenvelop
dna
virus
infect
papillomavirus
caus
benign
cancer
viral
oncogen
hpv
type
caus
cervic
cancer
counteract
sirna
engag
antiapoptot
hpv
oncogen
result
select
substanti
cell
death
hela
cancer
short
interf
rna
also
use
sever
combin
target
gene
result
consider
reduct
viral
replic
hela
cell
line
noteworthi
mention
sirna
show
harm
effect
control
cell
indic
meager
illustr
sirna
treatment
potenti
suppress
progress
cervic
cancer
polyomavirus
circular
dna
clinic
relev
caus
merkel
cell
carcinoma
aggress
type
squamou
cancer
merkel
cell
polyomaviru
antigen
protein
involv
replic
play
major
role
viral
infect
merkel
cell
polyomaviru
activ
restrain
ration
design
sirna
molecul
treatment
merkel
cell
carcinoma
genom
similarli
polyomaviru
bk
bkv
found
induc
malign
transform
repress
oncogen
shown
hinder
transform
cell
short
interf
rna
design
target
bkv
report
restrain
express
prpc
cell
line
block
result
diminish
growth
rate
cell
thu
suppress
poxvirus
singl
linear
dna
infect
vertebr
invertebr
vaccinia
viru
vacv
quintessenti
member
vacv
produc
dsrna
bind
protein
hamper
host
defens
mechan
like
interferon
sirna
inhibit
viru
replic
hela
cell
compar
control
addit
earli
late
gene
express
vacv
could
block
sirna
hepadnavirida
includ
envelop
virus
partial
genom
virus
famili
caus
liver
infect
anim
includ
hepat
b
viru
member
group
one
lead
caus
liver
cirrhosi
hepatocellular
carcinoma
short
interf
rna
develop
surfac
antigen
region
significantli
reduc
level
viral
transcript
well
secret
viral
antigen
famili
includ
import
pathogen
virus
like
viru
herp
simplex
viru
viru
respons
mainten
tumor
phenotyp
mani
cancer
type
found
univers
express
tumor
short
interf
rna
gener
mrna
abl
inhibit
translat
thu
block
tumor
surviv
hela
similarli
herp
simplex
viru
glycoprotein
e
respons
spread
immun
evas
target
glycoprotein
e
sirna
suppress
express
function
hacat
reovirus
genom
segment
dsrna
vector
express
sirna
target
gene
strain
reoviru
consider
block
multipl
step
viral
replic
machineri
studi
illustr
use
sirna
therapeut
agent
import
mean
investig
relationship
structur
function
viral
protein
arenavirus
contain
segment
rna
genom
ambisens
arenavirus
often
respons
fatal
hemorrhag
fever
peopl
lack
effect
medic
tackl
infect
lymphocyt
choriomening
viru
key
model
use
investig
arenaviru
link
pathogenesi
short
interf
rna
direct
l
polymeras
z
viral
mrna
stall
viral
growth
hek
host
paramyxovirida
rna
rsv
import
member
group
caus
lung
infect
young
age
peopl
worldwid
short
interf
rna
target
rsv
p
gene
balbc
mice
model
show
less
lung
pathogenesi
pulmonari
inflamm
gener
strong
antivir
reaction
later
given
rabi
viru
rv
member
famili
rhabdovirida
caus
fatal
zoonot
diseas
human
anim
respons
human
death
annual
asia
brandao
et
al
use
sirna
rabi
viru
nucleoprotein
mrna
decreas
viru
titer
worker
develop
sirna
target
rabi
viru
glycoprotein
nucleoprotein
show
remark
knockdown
effect
signific
inhibit
rv
multipl
order
virus
previous
known
bunyavirida
famili
includ
envelop
segment
rna
lack
effect
vaccin
therapi
bunyavirus
human
sirna
afford
attract
altern
exampl
model
hazara
viru
genu
nairoviru
inhibit
sirna
target
np
gene
similarli
sirna
develop
agnoprotein
john
cunningham
viru
etiolog
agent
demyelin
progress
multifoc
leukoencephalopathi
diseas
prove
effect
inhibitor
john
cunningham
viru
infect
nude
filovirida
famili
compris
filament
rna
virus
ebola
marburg
viru
marv
caus
sever
diseas
short
interf
rna
target
zair
ebolaviru
nucleoprotein
decreas
viral
titer
infect
short
interf
rna
use
degrad
marv
nucleocapsid
transcript
np
hela
cell
also
caus
strong
declin
express
marv
protein
viru
releas
suggest
role
viral
transcript
influenza
viru
caus
one
common
infect
human
although
antivir
drug
avail
use
limit
possibl
emerg
resist
viru
ge
et
al
found
sirna
pertain
conserv
region
infv
genom
inhibit
replic
picornavirus
nonenvelop
rna
virus
icosahedr
capsid
coxsackieviru
polioviru
two
virus
treatment
sirna
significantli
decreas
cell
death
parallel
reduct
coxsackieviru
replic
hela
cell
also
effici
coxsackieviru
sirna
display
antivir
activ
relat
enterovirus
coxsackieviru
hela
group
virus
contain
linear
one
member
chikungunya
viru
caus
agent
chikungunya
fever
emerg
import
arbovir
infect
public
health
concern
short
interf
rna
target
conserv
segment
mrna
pathogen
abl
drastic
reduc
viru
titer
vero
sever
acut
respiratori
syndrom
also
known
member
coronavirida
famili
whose
member
rna
genom
short
interf
rna
target
untransl
region
utr
pathogen
inhibit
replic
li
et
al
demonstr
sirna
use
provid
relief
viral
fever
decreas
viral
level
lower
acut
diffus
alveoli
damag
famili
encompass
spheric
envelop
virus
linear
posit
rna
genom
includ
mani
import
human
virus
like
hcv
dengu
viru
denv
hepat
c
viru
infect
caus
perman
damag
liver
hepatocellular
carcinoma
death
seo
et
al
target
multipl
segment
utr
viru
genom
use
sirna
achiev
reduct
activ
similar
approach
sirna
design
wnv
utr
express
system
vero
cell
result
suppress
wnv
replic
manner
also
indic
function
utr
wnv
dengu
viru
caus
sever
diseas
threaten
public
health
global
tropic
subtrop
place
exogen
introduc
sirna
direct
conserv
cycliz
sequenc
segment
denv
genom
effect
decreas
viral
titer
multipl
denv
strain
mice
illustr
potenti
sirna
tackl
genet
vari
dengu
zika
viru
recent
pose
global
health
threat
prompt
intens
research
control
scientist
found
conserv
utr
viru
genom
play
crucial
function
replic
therefor
ration
design
sirna
utr
predict
inhibit
studi
also
shown
silenc
host
endoplasm
reticulum
membran
complex
protein
compon
halt
replic
multipl
zika
viru
strain
hela
hepevirida
mainli
includ
hepat
e
viru
key
sourc
hepat
adult
particularli
high
mortal
pregnant
women
short
interf
rna
develop
helicas
replicas
gene
hepat
e
viru
found
effect
inhibit
viru
replic
well
retrovirida
famili
envelop
rna
virus
replic
host
cell
process
revers
note
sirna
inhibit
growth
aim
gene
host
cell
receptor
viral
gag
nef
protein
cell
studi
report
sirna
molecul
effici
hinder
preintegr
well
postintegr
infect
phase
hiv
life
larg
therapeut
potenti
offer
sirna
pathogen
virus
mani
consid
medic
use
near
futur
antivir
alreadi
enter
clinic
trial
eg
rsv
target
nucleocapsid
gene
phase
ii
direct
differ
target
x
hbv
phase
direct
hcv
phase
ii
target
multipl
gene
tat
tar
hiv
phase
direct
multipl
transcript
l
ebov
phase
rnai
therapi
also
prove
use
anim
virus
marek
diseas
viru
foot
mouth
diseas
viru
viru
signific
rnai
treatment
viral
infect
figur
briefli
summar
role
gene
silenc
combat
pathogen
virus
design
sirna
high
antivir
activ
challeng
task
mani
featur
influenc
sirna
efficaci
includ
gc
content
nucleotid
sirna
termini
thermodynam
properti
sirna
structur
access
target
also
sirna
develop
conserv
target
site
prevent
viral
escap
due
suggest
singl
target
site
might
enough
durabl
viral
silenc
use
multipl
sirna
sever
target
site
also
prevent
viral
addit
chemic
modifi
nucleotid
also
use
enhanc
stabil
reduc
effect
eg
modifi
sirna
use
hbv
infect
found
significantli
increas
activ
human
serum
compar
unmodifi
unaid
sirna
capabl
penetr
cellular
membran
due
neg
charg
besid
sirna
shown
elicit
immun
respons
vulner
nucleas
enzym
thu
suitabl
deliveri
agent
requir
effici
transport
sirna
target
cell
deliveri
sirna
desir
cell
lessen
amount
sirna
necessari
silenc
also
circumv
short
interf
rna
deliv
number
way
eg
encapsul
synthet
vehicl
cation
liposomesnanoparticl
sirna
conjug
cell
penetr
peptid
specif
antibodi
infect
liposom
frequent
use
deliveri
medium
wide
rang
drug
includ
sirna
method
often
involv
cation
lipid
overcom
neg
charg
associ
late
stabl
nucleic
acid
lipid
particl
use
effici
stabil
transport
morrissey
et
al
use
stabl
nucleic
acid
lipid
particl
deliv
sirna
hbv
effici
inhibit
viru
next
sirna
deliveri
vehicl
polyplex
afford
high
structur
physicochem
flexibl
shield
sirna
likewis
inorgan
nanoparticl
gener
calcium
phosphat
gold
carbon
iron
oxid
sometim
prefer
transport
sirna
due
small
size
increas
permeabl
comparison
liposom
polyplex
occasion
surfac
ligand
incorpor
nanoparticl
enhanc
select
target
diseas
plasmid
viral
vector
also
use
express
cassett
sustain
silenc
effect
howev
use
plasmid
limit
deliveri
effici
compar
viral
altern
direct
inject
infect
tissu
may
also
help
target
specif
although
larg
number
databas
design
predict
algorithm
avail
mammalian
sirna
bioinformat
resourc
develop
far
regard
viral
sirna
despit
huge
potenti
data
avail
viral
sirna
databas
avail
http
crddosddnetserversvirsirnadb
cover
detail
sirna
target
import
human
virus
databas
provid
detail
inform
sirna
sequenc
target
viru
gene
cell
line
assay
inhibit
also
use
sirna
analysi
tool
includ
sitaralign
align
sirna
sequenc
genom
sequenc
repres
similar
line
hiv
sirna
databas
avail
http
crddosddnetraghavahivsir
furnish
detail
experiment
test
sirnasshort
hairpin
rna
aim
divers
hiv
genom
segment
hivsirmut
subdatabas
access
http
crddosddnetraghavahivsirhivescseqphp
provid
inform
escap
mutat
togeth
nucleotid
mismatch
amid
target
gene
sirna
molecul
effect
sirna
sirna
develop
inhibit
certain
gene
equal
success
varieti
sirna
design
rule
predict
method
publish
basic
procedur
sirna
design
ground
frequenc
certain
nucleotid
multipl
locat
sirna
sequenc
anticip
elbashir
et
reynold
et
et
amarzguioui
et
jagla
et
siviru
web
server
access
http
sivirusrnaijp
make
use
guidelin
select
effect
sirna
virus
siviru
provid
sirna
sequenc
direct
conserv
region
virus
like
hiv
hcv
infv
minimum
although
mani
machin
learn
techniqu
like
boost
genet
artifici
neural
support
vector
use
design
mammalian
sirna
howev
perform
satisfactori
viral
sirna
may
due
fact
method
train
viral
sirna
viral
sirna
predictor
avail
http
crddosddnetserversvirsirnapr
origin
algorithm
calcul
inhibit
potenti
viral
sirna
support
vector
method
predict
activ
viral
sirna
algorithm
develop
use
publish
viral
sirna
use
mani
featur
nucleotid
frequenc
thermodynam
factor
nucleotid
locat
predict
compet
sirna
target
pathogen
onlin
resourc
tabl
facilit
research
select
design
effici
sirna
antivir
therapeut
develop
short
interf
gene
silenc
surfac
potent
strategi
studi
cellular
network
well
precis
knockdown
diseas
caus
factor
howev
sirna
confront
shortcom
like
viru
escap
ineffici
cellular
uptak
poor
stabil
effect
viru
escap
overcom
target
conserv
viral
factor
involv
cellular
uptak
improv
use
synthet
nanoparticl
compos
polym
lipid
conjug
also
incorpor
target
ligand
far
sirna
stabil
concern
chemic
modif
like
thioat
linkag
may
use
prolong
also
detail
identif
cellular
pathway
immunorecognit
rna
allow
develop
method
avoid
immunostimulatori
oligonucleotid
motif
sirna
also
multipl
sirna
express
vector
may
use
maxim
would
also
help
make
use
bioinformat
approach
identifi
potenti
target
site
well
design
sirna
optimum
featur
preliminari
author
compet
interest
